Literature DB >> 24082023

A Canadian screening program for hepatitis C: is now the time?

Hemant A Shah, Jenny Heathcote, Jordan J Feld.   

Abstract

Mesh：

Year:  2013        PMID： 24082023      PMCID： PMC3796597          DOI： 10.1503/cmaj.121872

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  25 in total

Review 1.  Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.

Authors:  J M Micallef; J M Kaldor; G J Dore
Journal:  J Viral Hepat       Date:  2006-01       Impact factor: 3.728

2.  Human immunodeficiency virus, hepatitis B, and hepatitis C seroprevalence in a Canadian trauma population.

Authors:  George Xeroulis; Kenji Inaba; Tanya Charyk Stewart; Rob Lannigan; Daryl Gray; Richard Malthaner; N Gil Parry; Murray Girotti
Journal:  J Trauma       Date:  2005-07

3.  Management of hepatitis C patients by primary care physicians in the USA: results of a national survey.

Authors:  T M Shehab; S S Sonnad; A S Lok
Journal:  J Viral Hepat       Date:  2001-09       Impact factor: 3.728

4.  Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature.

Authors:  C Colin; D Lanoir; S Touzet; L Meyaud-Kraemer; F Bailly; C Trepo
Journal:  J Viral Hepat       Date:  2001-03       Impact factor: 3.728

5.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

6.  Outcome of screening for hepatitis C virus infection based on risk factors.

Authors:  Carol Mallette; Maura A Flynn; Kittichai Promrat
Journal:  Am J Gastroenterol       Date:  2007-09-25       Impact factor: 10.864

7.  Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

Authors:  Bart J Veldt; E Jenny Heathcote; Heiner Wedemeyer; Juerg Reichen; W Peter Hofmann; Stefan Zeuzem; Michael P Manns; Bettina E Hansen; Solko W Schalm; Harry L A Janssen
Journal:  Ann Intern Med       Date:  2007-11-20       Impact factor: 25.391

8.  Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Authors:  Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

9.  Changing trends in hepatitis C-related mortality in the United States, 1995-2004.

Authors:  Matthew Wise; Stephanie Bialek; Lyn Finelli; Beth P Bell; Frank Sorvillo
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

10.  Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.

Authors:  Charlotte Hsieh Ahern; Yu Shen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-03       Impact factor: 4.254
View more
  24 in total

1.  Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline.

Authors:  Daniel John Smyth; Duncan Webster; Lisa Barrett; Mark MacMillan; Lisa McKnight; Frank Schweiger
Journal:  Can J Gastroenterol Hepatol       Date:  2014-11

2.  Hospital stays for hepatitis B or C virus infection or primary liver cancer among immigrants: a census-linked population-based cohort study.

Authors:  Edward Ng; Robert P Myers; Doug Manuel; Claudia Sanmartin
Journal:  CMAJ Open       Date:  2016-04-28

3.  Acceptability and yield of birth-cohort screening for hepatitis C virus in a Canadian population being screened for colorectal cancer: a cross-sectional study.

Authors:  Robert P Myers; Pam Crotty; Susanna Town; Janine English; Kevin Fonseca; Raymond Tellier; Mark G Swain; S Elizabeth McGregor; Steven J Heitman; Robert J Hilsden
Journal:  CMAJ Open       Date:  2015-01-13

4.  Recommendations on hepatitis C screening for adults.

Authors:  Roland Grad; Brett Thombs; Marcello Tonelli; Maria Bacchus; Richard Birtwhistle; Scott Klarenbach; Harminder Singh; Veronique Dorais; Nathalie Holmes; Wendy Martin; Rachel Rodin; Alejandra Jaramillo Garcia
Journal:  CMAJ       Date:  2017-04-24       Impact factor: 8.262

5.  Identifying those infected with hepatitis C virus.

Authors:  Eric M Yoshida; Eberhard Renner; Philip Wong; Mel Krajden
Journal:  CMAJ       Date:  2017-06-26       Impact factor: 8.262

6.  Screening for HCV.

Authors:  William W L Wong; Murray Krahn
Journal:  CMAJ       Date:  2014-03-04       Impact factor: 8.262

7.  Screening for HCV.

Authors:  Fiona G Kouyoumdjian; Aaron Orkin; Kathleen Dooling; Michael Schwandt
Journal:  CMAJ       Date:  2014-03-04       Impact factor: 8.262

8.  An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver.

Authors:  Robert P Myers; Hemant Shah; Kelly W Burak; Curtis Cooper; Jordan J Feld
Journal:  Can J Gastroenterol Hepatol       Date:  2015-01-13

9.  Gaps in the hepatitis C continuum of care among sex workers in Vancouver, British Columbia: Implications for voluntary hepatitis C virus testing, treatment and care.

Authors:  M Eugenia Socías; Kate Shannon; Julio S Montaner; Silvia Guillemi; Sabina Dobrer; Paul Nguyen; Shira Goldenberg; Kathleen Deering
Journal:  Can J Gastroenterol Hepatol       Date:  2015-10-22

10.  Model-based projection of health and economic effects of screening for hepatitis C in Canada.

Authors:  William W L Wong; Aysegul Erman; Jordan J Feld; Murray Krahn
Journal:  CMAJ Open       Date:  2017-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.